WebCancer Therapy Evaluation Program Adverse Event Reporting System (CTEP-AERS) CTEP-AERS On-line Application; CTEP-AERS Home Page. This page includes an … WebCTEP-AERS Transition Timeline • Training: – Began end of October 2013 and will continue as needed throughout 2014 and beyond – Standing trainings (3 per week) conducted beginning of December 2013 • Pilot: – October – December 2013 • CTEP-AERS open to full community for use in place of AdEERS for all relevant studies:
Cancer and Leukemia Group B
Webfor CTEP-AERS integrated studies) Yes A Yes/No flag entered by site indicating they view the event as serious. No Date of Onset (CDASH: Start Date) Yes, if study has registration intent or Cycle/Course # is not provided Date that the event began for specified grade. No Date Resolved (CDASH: End Date) Yes, if study has registration intent WebCancer and Leukemia Group B cigars and trigger points
Alliance
WebDec 15, 2004 · agent under a CTEP IND •Source: – AdEERS –IB – Package inserts – Literature (e.g., abstracts, publications) • Distributed to every Investigator with an approved LOI or active CTEP protocol (includes updates) • Updates may or may not require protocol amendment • Inquires: [email protected] WebCTEP RESOURCES Agent Management Cancer Trials Support Unit (CTSU) Central Institutional Review Board (CIRB) CTEP Forms, Templates and Documents CTEP … WebVersion Date: 09/10/2024 1 Update #06 ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY ALLIANCE A091404 A PHASE II STUDY OF ENZALUTAMIDE (NSC# 766085) FOR PATIENTS WITH ANDROGEN RECEPTOR POSITIVE SALIVARY CANCERS Industry-supplied agent(s): Enzalutamide (IND EXEMPT) ClinicalTrials.gov … cigars and palm trees